Literature DB >> 15624249

Osteoporotic fragility fractures in African Americans: under-recognized and undertreated.

Neelofar M Alam1, Juanita A Archer, Euni Lee.   

Abstract

PURPOSE: To determine the frequency of diagnosing and treating osteoporosis in patients with fragility fractures.
METHODOLOGY: Retrospective review of medical records from January 1992 to December 2002 at Howard University Hospital, an urban tertiary care teaching hospital with a predominantly African-American population. Men 50 years old and women 45 years old with fractures caused by low impact falls (fragility fractures) were included. The diagnosis of osteoporosis was based on history, x-rays and pathology reports as indicated by ICD-9 codes (733.00-733.09) and review of medical records. MAIN
FINDINGS: Of 58,841 patients who were admitted during the study period, 1,248 patients (2.1%) had fractures. There were 323 patients (65%) who had fractures secondary to low-impact falls. However, only 29 (8.9%) of these had a diagnosis of osteoporosis. Of these, only five (19%) patients were discharged on antiosteoporotic medications, and only one patient was discharged with a bisphosphonate therapy. No patient had DXA scans.
CONCLUSIONS: In the population studied, osteoporosis was missed in the majority of the patients as an underlying cause for fragility fractures in African Americans. These results strongly suggest that physicians should be more aware of osteoporosis as an essential cause of fragility fractures. Early recognition and treatment in African Americans and other ethnic groups can significantly decrease the morbidity, mortality and the healthcare costs.

Entities:  

Mesh:

Year:  2004        PMID: 15624249      PMCID: PMC2568669     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  20 in total

1.  Modifiable and nonmodifiable factors associated with osteoporosis in postmenopausal women: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  A M Snelling; C J Crespo; M Schaeffer; S Smith; L Walbourn
Journal:  J Womens Health Gend Based Med       Date:  2001 Jan-Feb

Review 2.  Epidemiology of osteoporosis.

Authors:  E M Lau
Journal:  Best Pract Res Clin Rheumatol       Date:  2001-07       Impact factor: 4.098

Review 3.  Osteoporosis and African American women.

Authors:  A D Bohannon
Journal:  J Womens Health Gend Based Med       Date:  1999-06

4.  Evaluation of osteoporosis treatment in seniors after hip fracture.

Authors:  A G Juby; C M De Geus-Wenceslau
Journal:  Osteoporos Int       Date:  2002-03       Impact factor: 4.507

5.  Outcomes and secondary prevention strategies for male hip fractures.

Authors:  Rebecca L Riley; Molly L Carnes; Adalsteinn Gudmundsson; Mary E Elliott
Journal:  Ann Pharmacother       Date:  2002-01       Impact factor: 3.154

6.  Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture.

Authors:  Sheryl L Follin; Jennifer N Black; Michael T McDermott
Journal:  Pharmacotherapy       Date:  2003-02       Impact factor: 4.705

7.  Investigation and treatment of osteoporosis in patients with fragility fractures.

Authors:  E E Hajcsar; G Hawker; E R Bogoch
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

8.  The management of osteoporosis following hip fracture: have we improved our care?

Authors:  Sachin Bahl; Penelope S Coates; Susan L Greenspan
Journal:  Osteoporos Int       Date:  2003-10-16       Impact factor: 4.507

9.  Undertreatment of osteoporosis in men with hip fracture.

Authors:  Gary M Kiebzak; Garth A Beinart; Karen Perser; Catherine G Ambrose; Sherwin J Siff; Michael H Heggeness
Journal:  Arch Intern Med       Date:  2002-10-28

10.  Hip fracture patients are not treated for osteoporosis: a call to action.

Authors:  J Timothy Harrington; Susan B Broy; Angela M Derosa; Angelo A Licata; David A Shewmon
Journal:  Arthritis Rheum       Date:  2002-12-15
View more
  9 in total

1.  Racial disparity in treatment of osteoporosis after diagnosis.

Authors:  I Hamrick; L M Whetstone; D M Cummings
Journal:  Osteoporos Int       Date:  2006-07-27       Impact factor: 4.507

Review 2.  Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.

Authors:  Gloria J Morris; Edith P Mitchell
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

3.  Correlations of nursing home characteristics with prescription of osteoporosis medications.

Authors:  Seema Parikh; M Alan Brookhart; Margaret Stedman; Jerry Avorn; Helen Mogun; Daniel H Solomon
Journal:  Bone       Date:  2011-02-21       Impact factor: 4.398

Review 4.  Treatment of osteoporosis: current state of the art.

Authors:  Irene Hamrick; Sarina Schrager; Ann Marie Nye
Journal:  Wien Med Wochenschr       Date:  2014-12-12

5.  Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

Authors:  B Dawson-Hughes; A N A Tosteson; L J Melton; S Baim; M J Favus; S Khosla; R L Lindsay
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

6.  Incidence of fractures compared to cardiovascular disease and breast cancer: the Women's Health Initiative Observational Study.

Authors:  J A Cauley; N S Wampler; J M Barnhart; L Wu; M Allison; Z Chen; S Hendrix; J Robbins; R D Jackson
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

Review 7.  African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox.

Authors:  John F Aloia
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

8.  Association between a literature-based genetic risk score and bone mineral density of African American women in Women Health Initiative Study.

Authors:  X Xiao; Q Wu
Journal:  Osteoporos Int       Date:  2019-12-01       Impact factor: 4.507

9.  Interstate variation in the burden of fragility fractures.

Authors:  Alison B King; Anna N A Tosteson; John B Wong; Daniel H Solomon; Russel T Burge; Bess Dawson-Hughes
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.